1. Home
  2. ANEB vs CXAI Comparison

ANEB vs CXAI Comparison

Compare ANEB & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANEB
  • CXAI
  • Stock Information
  • Founded
  • ANEB 2020
  • CXAI N/A
  • Country
  • ANEB United States
  • CXAI United States
  • Employees
  • ANEB N/A
  • CXAI N/A
  • Industry
  • ANEB Biotechnology: Pharmaceutical Preparations
  • CXAI EDP Services
  • Sector
  • ANEB Health Care
  • CXAI Technology
  • Exchange
  • ANEB Nasdaq
  • CXAI Nasdaq
  • Market Cap
  • ANEB 36.7M
  • CXAI 33.9M
  • IPO Year
  • ANEB 2021
  • CXAI N/A
  • Fundamental
  • Price
  • ANEB $1.33
  • CXAI $1.61
  • Analyst Decision
  • ANEB Buy
  • CXAI
  • Analyst Count
  • ANEB 1
  • CXAI 0
  • Target Price
  • ANEB $8.00
  • CXAI N/A
  • AVG Volume (30 Days)
  • ANEB 12.4K
  • CXAI 882.7K
  • Earning Date
  • ANEB 02-14-2025
  • CXAI 11-12-2024
  • Dividend Yield
  • ANEB N/A
  • CXAI N/A
  • EPS Growth
  • ANEB N/A
  • CXAI N/A
  • EPS
  • ANEB N/A
  • CXAI N/A
  • Revenue
  • ANEB N/A
  • CXAI $7,200,000.00
  • Revenue This Year
  • ANEB N/A
  • CXAI $3.86
  • Revenue Next Year
  • ANEB N/A
  • CXAI $100.00
  • P/E Ratio
  • ANEB N/A
  • CXAI N/A
  • Revenue Growth
  • ANEB N/A
  • CXAI N/A
  • 52 Week Low
  • ANEB $0.80
  • CXAI $1.09
  • 52 Week High
  • ANEB $3.30
  • CXAI $7.07
  • Technical
  • Relative Strength Index (RSI)
  • ANEB 36.62
  • CXAI 47.82
  • Support Level
  • ANEB $1.45
  • CXAI $1.46
  • Resistance Level
  • ANEB $1.61
  • CXAI $1.64
  • Average True Range (ATR)
  • ANEB 0.12
  • CXAI 0.10
  • MACD
  • ANEB -0.03
  • CXAI 0.01
  • Stochastic Oscillator
  • ANEB 0.00
  • CXAI 82.61

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

About CXAI CXApp Inc.

CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.

Share on Social Networks: